<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Chen, Jun</dc:creator>
  <dc:creator>Young, Susan M.</dc:creator>
  <dc:creator>Allen, Chris</dc:creator>
  <dc:creator>Seeber, Andrew</dc:creator>
  <dc:creator>Péli-Gulli, Marie-Pierre</dc:creator>
  <dc:creator>Panchaud, Nicolas</dc:creator>
  <dc:creator>Waller, Anna</dc:creator>
  <dc:creator>Ursu, Oleg</dc:creator>
  <dc:creator>Yao, Tuanli</dc:creator>
  <dc:creator>Golden, Jennifer E.</dc:creator>
  <dc:creator>Strouse, J. Jacob</dc:creator>
  <dc:creator>Carter, Mark B.</dc:creator>
  <dc:creator>Kang, Huining</dc:creator>
  <dc:creator>Bologa, Cristian G.</dc:creator>
  <dc:creator>Foutz, Terry D.</dc:creator>
  <dc:creator>Edwards, Bruce S.</dc:creator>
  <dc:creator>Peterson, Blake R.</dc:creator>
  <dc:creator>Aubé, Jeffrey</dc:creator>
  <dc:creator>Werner-Washburne, Margaret</dc:creator>
  <dc:creator>Loewith, Robbie J.</dc:creator>
  <dc:creator>De Virgilio, Claudio</dc:creator>
  <dc:creator>Sklar, Larry A.</dc:creator>
  <dc:date>2012-01-19</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">TOR (target of rapamycin) is a serine/threonine kinase, evolutionarily conserved from  yeast to human, which functions as a fundamental controller of cell growth. The  moderate clinical benefit of rapamycin in mTOR-based therapy of many cancers  favors the development of new TOR inhibitors. Here we report a high-throughput flow  cytometry multiplexed screen using five GFP-tagged yeast clones that represent the  readouts of four branches of the TORC1 signaling pathway in budding yeast. Each  GFP-tagged clone was differentially color-coded, and the GFP signal of each clone  was measured simultaneously by flow cytometry, which allows rapid prioritization of  compounds that likely act through direct modulation of TORC1 or proximal signaling  components. A total of 255 compounds were confirmed in dose–response analysis to  alter GFP expression in one or more clones. To validate the concept of the high-  throughput screen, we have characterized CID 3528206, a small molecule most likely  to act on TORC1 as it alters GFP expression in all five GFP clones in a manner  analogous to that of rapamycin. We have shown that CID 3528206 inhibited yeast cell  growth and that CID 3528206 inhibited TORC1 activity both in vitro and in vivo with  EC50's of 150 nM and 3.9 μM, respectively. The results of microarray analysis and  yeast GFP collection screen further support the notion that CID 3528206 and  rapamycin modulate similar cellular pathways. Together, these results indicate that the  HTS has identified a potentially useful small molecule for further development of TOR  inhibitors.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/302314</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/302314/files/vir_ism.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/302314/files/vir_ism_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1021/cb200452r</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>ACS Chemical Biology. - 2012, vol. 7, no. 4, p. 715–722</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Identification of a small molecule yeast TORC1 inhibitor with a multiplex screen based on flow cytometry</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
